Provided by Tiger Trade Technology Pte. Ltd.

Icon PLC

150.59
+5.203.58%
Post-market: 151.330.7400+0.49%19:34 EST
Volume:1.78M
Turnover:265.24M
Market Cap:11.50B
PE:20.15
High:153.15
Open:145.23
Low:144.51
Close:145.39
52wk High:211.00
52wk Low:125.10
Shares:76.36M
Float Shares:75.38M
Volume Ratio:1.43
T/O Rate:2.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.47
EPS(LYR):9.53
ROE:6.27%
ROA:4.20%
PB:1.23
PE(LYR):15.80

Loading ...

Is ICON (ICLR) Quietly Redefining Its Oncology Moat With the Brian Moran Institute Expansion?

Simply Wall St.
·
Yesterday

ICON plc Expands Oncology Research Network With New Illinois Cancer Institute

Reuters
·
Jan 28

ICON Plc : TD Cowen Raises Target Price to $183 From $172

THOMSON REUTERS
·
Jan 22

Is ICON (ICLR) Price Weakness Creating A Long Term Opportunity For Investors

Simply Wall St.
·
Jan 17

ICON’s Role in Zealand Pharma’s Petrelintide Kidney Study: What Trial Completion Means for Investors

TIPRANKS
·
Jan 16

Icon price target lowered to $217 from $220 at Baird

TIPRANKS
·
Jan 09

ICON Plc Down Nearly 10%, on Pace for Largest Percent Decrease Since October 2024 -- Data Talk

Dow Jones
·
Jan 09

Icon Cut to Hold From Buy by Truist Securities

Dow Jones
·
Jan 08

ICON Plc : Truist Securities Cuts to Hold From Buy; Cuts Target Price to $222 From $231

THOMSON REUTERS
·
Jan 08

BUZZ-Life sciences and contract research stocks navigate turbulence in 2025

Reuters
·
Dec 31, 2025

ICON (ICLR): Assessing Valuation After a Recent 9% Share Price Rebound

Simply Wall St.
·
Dec 23, 2025

Icon Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Dec 16, 2025

How Investors May Respond To ICON (ICLR) Surveying AI‑Driven R&D Resilience And Bottlenecks In Biotech

Simply Wall St.
·
Dec 11, 2025

ICON Survey Highlights China's Biotech Dominance and Global Funding Shifts

Reuters
·
Dec 09, 2025

BRIEF-Icon Survey Reveals Increasing Clinical Trial Startup Delays

Reuters
·
Dec 02, 2025

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

THOMSON REUTERS
·
Dec 02, 2025

ICON Plc : Bmo Initiates Coverage With Market Perform Rating; Price Target $175

THOMSON REUTERS
·
Nov 13, 2025

ICON plc Leadership to Present at Jefferies London Healthcare Conference

Reuters
·
Nov 12, 2025

DaVita Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Nov 12, 2025

Analysts Conflicted on These Healthcare Names: BioNTech SE (BNTX), Icon (ICLR) and Innovent Biologics (OtherIVBXF)

TIPRANKS
·
Oct 25, 2025